
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19
Shahab Mahmoudvand, Somayeh Shokri
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 4
Open Access | Times Cited: 40
Shahab Mahmoudvand, Somayeh Shokri
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 4
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin
Paweł M. Wydorski, J. Osipiuk, Benjamin T. Lanham, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Paweł M. Wydorski, J. Osipiuk, Benjamin T. Lanham, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Molecular Docking - Recent Advances
Erman Salih İstifli, Erman Salih, Sefika Feyza Maden, et al.
Biomedical engineering (2022)
Open Access | Times Cited: 5
Erman Salih İstifli, Erman Salih, Sefika Feyza Maden, et al.
Biomedical engineering (2022)
Open Access | Times Cited: 5
Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes
Jinlin Tan, Zhilong Wu, Peipei Hu, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1008-1008
Open Access | Times Cited: 5
Jinlin Tan, Zhilong Wu, Peipei Hu, et al.
Pathogens (2022) Vol. 11, Iss. 9, pp. 1008-1008
Open Access | Times Cited: 5
Alnustone inhibits Streptococcus pneumoniae virulence by targeting pneumolysin and sortase A
Can Zhang, Yanhong Deng, Xinyu Wang, et al.
Fitoterapia (2022) Vol. 162, pp. 105261-105261
Open Access | Times Cited: 4
Can Zhang, Yanhong Deng, Xinyu Wang, et al.
Fitoterapia (2022) Vol. 162, pp. 105261-105261
Open Access | Times Cited: 4
Zinc as a Possible Critical Element to Prevent Harmful Effects of COVID-19 on Testicular Function: a Narrative Review
Marouane Chemek, Ammar Kadi, Fatimah Kadhim Ibrahim AL- Mahdawi, et al.
Reproductive Sciences (2024)
Closed Access
Marouane Chemek, Ammar Kadi, Fatimah Kadhim Ibrahim AL- Mahdawi, et al.
Reproductive Sciences (2024)
Closed Access
Molecular insights into natural product compounds targeting papain protease of SARS-CoV-2 through molecular dynamics simulation
Chananya Rajchakom, Nitchakan Darai, Thitiya Boonma, et al.
Monatshefte für Chemie - Chemical Monthly (2024)
Closed Access
Chananya Rajchakom, Nitchakan Darai, Thitiya Boonma, et al.
Monatshefte für Chemie - Chemical Monthly (2024)
Closed Access
Highlights on molecular targets in the management of COVID-19: Possible role of pharmacogenomics
Romany H. Thabet, Noor A. Massadeh, Omar B. Badarna, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 1, pp. 030006052311537-030006052311537
Open Access | Times Cited: 1
Romany H. Thabet, Noor A. Massadeh, Omar B. Badarna, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 1, pp. 030006052311537-030006052311537
Open Access | Times Cited: 1
Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
Onkardeep Kaur, Pawan Singh
Lung India (2023) Vol. 40, Iss. 5, pp. 483-483
Open Access | Times Cited: 1
Onkardeep Kaur, Pawan Singh
Lung India (2023) Vol. 40, Iss. 5, pp. 483-483
Open Access | Times Cited: 1
Identification of DAXX As A Restriction Factor Of SARS-CoV-2 Through A CRISPR/Cas9 Screen
Alice Mac Kain, Ghizlane Maarifi, Sophie‐Marie Aicher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Alice Mac Kain, Ghizlane Maarifi, Sophie‐Marie Aicher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Design of a multi‐epitope‐based vaccine consisted of immunodominant epitopes of structural proteins of SARS‐CoV‐2 using immunoinformatics approach
Shahab Mahmoudvand, Hadi Esmaeili Gouvarchin Ghaleh, Farid Azizi Jalilian, et al.
Biotechnology and Applied Biochemistry (2022) Vol. 70, Iss. 3, pp. 1189-1205
Open Access | Times Cited: 2
Shahab Mahmoudvand, Hadi Esmaeili Gouvarchin Ghaleh, Farid Azizi Jalilian, et al.
Biotechnology and Applied Biochemistry (2022) Vol. 70, Iss. 3, pp. 1189-1205
Open Access | Times Cited: 2
Beginnings of coinhibition
Nicholas R. StC. Sinclair
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 5
Open Access | Times Cited: 2
Nicholas R. StC. Sinclair
Scandinavian Journal of Immunology (2021) Vol. 94, Iss. 5
Open Access | Times Cited: 2
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin
Łukasz A. Joachimiak, J. Osipiuk, Paweł M. Wydorski, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Łukasz A. Joachimiak, J. Osipiuk, Paweł M. Wydorski, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline
Aldo Herrera-Rodulfo, Mariana Andrade-Medina, Mauricio Carrillo‐Tripp
Biomedical engineering (2022)
Open Access | Times Cited: 1
Aldo Herrera-Rodulfo, Mariana Andrade-Medina, Mauricio Carrillo‐Tripp
Biomedical engineering (2022)
Open Access | Times Cited: 1
Systematic Review and Meta-Analysis Protocol of the Efficacy and Safety of COVID-19 Drug Candidates Targeting Host Enzymes Involved in Immune Response
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
Vaishali Waman, Paul Ashford, Su Datt Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Vaishali Waman, Paul Ashford, Su Datt Lam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access